Bioventus (BVS) Net Income towards Common Stockholders (QoQ) (2020 - 2026)
Bioventus (BVS) Net Income towards Common Stockholders (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Bioventus | 837.84 Mn | 801.99 Mn | 90.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -77.21% |
| Dec 31, 2025 | 332.30% |
| Sep 27, 2025 | -56.79% |
| Jun 28, 2025 | 379.11% |
| Apr 1, 2023 | -218.13% |
| Dec 31, 2022 | 47.62% |
| Oct 1, 2022 | -15,851.07% |
| Jul 2, 2022 | 30.17% |
| Apr 2, 2022 | -1,504.00% |
| Dec 31, 2021 | 98.90% |
| Oct 2, 2021 | 78.95% |
| Jul 3, 2021 | -143.95% |
| Apr 3, 2021 | 989.65% |
| Dec 31, 2020 | -71.74% |
| Sep 26, 2020 | 233.19% |
| Jun 27, 2020 | -157.03% |